Abliva AB (NEVPF)
0.01
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Abliva Profit Margin (Quarterly): -18.42K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.42K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -81.03K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -76.81K% |
| September 30, 2021 | -41.00K% |
| June 30, 2021 | -168.4K% |
| March 31, 2021 | |
| December 31, 2020 | -11.77K% |
| September 30, 2020 | |
| June 30, 2020 | -20.94K% |
| March 31, 2020 | -206.7K% |
| December 31, 2019 | -55.32K% |
| September 30, 2019 | |
| June 30, 2019 | -24.43K% |
| March 31, 2019 | |
| December 31, 2018 | -297.0K% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | -61.46K% |
| December 31, 2016 | -92.66K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -624.4% |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | -48.25% |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -53.76% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | -47.48% |
| September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-206.7K%
Minimum
Mar 2020
-11.77K%
Maximum
Dec 2020
-70.49K%
Average
-48.16K%
Median
Profit Margin (Quarterly) Benchmarks
| Karolinska Development AB | 44.16% |
| Calliditas Therapeutics AB | -4.07% |
| Oncopeptides AB | -1.45K% |
| Olink Holding AB | -55.87% |
| BioInvent International AB | -1.31K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.85% |
| Return on Assets | -69.71% |
| Return on Invested Capital | -77.85% |
| Operating Margin (Quarterly) | -20.04K% |
| Return on Net Operating Assets | -108.9% |